Feasibility of Next-generation Sequencing of Liquid Biopsy (Circulating Tumor DNA) Samples and Tumor Tissue from Patients with Metastatic Prostate Cancer in a Real-world Clinical Setting in Germany.
Philipp MandelBenedikt HoehClara HumkeClaudia DoeringMike WenzelCristina Cano GarciaNina FuhrFlorestan KollAnne FasslDerya TilkiThomas SteuberIris FaullJan JerochSilvana EbnerChristina SchmittHenning ReisJens KöllermannKonstantinos D KokkaliarisMelanie C DemesFelix K H ChunPeter J WildPublished in: European urology focus (2024)
Our study shows that genetic tests for both tumor tissue and blood samples results in higher rates of detection of BRCA1/2 gene alterations in patients with metastatic prostate cancer.